ACR Convergence 2021

November 5-9, 2021. All Virtual.

View by Number View by Title View Sessions

View by Date

Tuesday, November 9, 2021

8:30AM-10:30AM: Abstract Number: 1656

Women with Rheumatoid Arthritis Have More Multimorbidity Than Men in a Large Nationwide US Study

RA – Diagnosis, Manifestations, & Outcomes Poster IV: Outcomes, Trajectory of Disease, & Epidemiology (1645–1673)

9:00AM-9:15AM: Abstract Number: 1889

Arthritogenic T Cells Harbor a Transcriptional Program of T Cell Activation and a Repertoire Pruned by Endogenous Superantigen

Abstracts: RA – Animal Models (1889–1892)

9:15AM-9:30AM: Abstract Number: 1890

Cellular Origin and Functions of Osteoclasts in Inflammatory Arthritis

Abstracts: RA – Animal Models (1889–1892)

9:30AM-9:45AM: Abstract Number: 1891

Variable Effects of Testosterone on Male versus Female Derived Macrophages in Inflammatory Arthritis

Abstracts: RA – Animal Models (1889–1892)

9:45AM-10:00AM: Abstract Number: 1892

Promotion of Autoimmune Arthritis via Tryptophan Metabolism and Production of the Bacterial-Derived Tryptophan Metabolite Indole

Abstracts: RA – Animal Models (1889–1892)

10:30AM-10:45AM: Abstract Number: 1893

“From Where I Stand”: Using Multiple Anchors Yields Different Benchmarks for Meaningful Improvement and Worsening in the Rheumatoid Arthritis Flare Questionnaire (RA-FQ)

Abstracts: Measures & Measurement of Healthcare Quality (1893–1896)

10:30AM-10:45AM: Abstract Number: 1897

A Randomized Double-Blind Controlled Trial of Intensive Serum Urate Lowering with Oral Urate-Lowering Therapy for Erosive Gout

Abstracts: Metabolic & Crystal Arthropathies – Basic & Clinical Science (1897–1900)

10:30AM-10:45AM: Abstract Number: L16

Breakthrough COVID-19 Infections Post-vaccination Among Immunocompromised Patients with Autoimmune or Inflammatory Rheumatic Diseases: A Retrospective Cohort Analysis from a U.S. Nationally-sampled Electronic Medical Record Data Repository

Late-Breaking Abstracts (L16 - L21)

10:30AM-10:45AM: Abstract Number: 1901

Severe Foot Symptoms Are Associated with Mortality: The Johnston County Osteoarthritis Project

Abstracts: Orthopedics, Low Back Pain, & Rehabilitation (1901–1904)

10:45AM-11:00AM: Abstract Number: L17

Additional Heterologous versus Homologous Booster Vaccination in Immunosuppressed Patients Without SARS-CoV-2 Antibody Seroconversion After Primary mRNA Vaccination: A Randomized Controlled Trial

Late-Breaking Abstracts (L16 - L21)

10:45AM-11:00AM: Abstract Number: 1902

Gait Alterations Associated with Worsening Knee Pain over 2 Years: A Machine-learning Approach in the MultiCenter Osteoarthritis Study

Abstracts: Orthopedics, Low Back Pain, & Rehabilitation (1901–1904)

10:45AM-11:00AM: Abstract Number: 1894

Natural Language Processing Tool for Extraction of Patient-Reported Outcomes from a National Multi-Electronic Health Records Registry

Abstracts: Measures & Measurement of Healthcare Quality (1893–1896)

10:45AM-11:00AM: Abstract Number: 1898

Risk of Major Adverse Cardiovascular Events in a Large Cohort of Patients with Acute Calcium Pyrophosphate Crystal Arthritis

Abstracts: Metabolic & Crystal Arthropathies – Basic & Clinical Science (1897–1900)

11:00AM-11:15AM: Abstract Number: 1895

Achievement of Target Serum Uric Acid Among Gout Patients Treated with Long-term Urate Lowering Therapy in the ACR’s Rheumatology Informatics System for Effectiveness (RISE) Registry

Abstracts: Measures & Measurement of Healthcare Quality (1893–1896)

11:00AM-11:15AM: Abstract Number: 1903

Does Limited Stair Climbing Lead to Poor Future Health? The Relationship Between Short-term Trajectories of Stair Climbing Frequency and Incident Slow Gait Speed over 1 and 2 Years in Adults with Knee Osteoarthritis

Abstracts: Orthopedics, Low Back Pain, & Rehabilitation (1901–1904)

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].